galantamine has been researched along with Ambulation Disorders, Neurologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khaĭmov, DA; Khalimov, RR; Krasakov, IV; Litvinenko, IV; Trufanov, AG | 1 |
| Bouchard, K; Hohnadel, E; Terry, AV | 1 |
1 trial(s) available for galantamine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
[New approach to gait disorders therapy in late stages of Parkinson's disease].
Topics: Aged; Biological Availability; Cholinesterase Inhibitors; Cognition Disorders; Combined Modality Therapy; Female; Gait; Gait Disorders, Neurologic; Galantamine; Humans; Male; Middle Aged; Monitoring, Physiologic; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Severity of Illness Index; Synaptic Transmission; Transcranial Magnetic Stimulation; Treatment Outcome | 2012 |
1 other study(ies) available for galantamine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Drug Interactions; Gait Disorders, Neurologic; Galantamine; Indans; Inhibition, Psychological; Male; Nootropic Agents; Piperidines; Rats; Reflex, Startle; Scopolamine | 2007 |